| Single-cell RNA-seq analysis of retinal development identifies NFI factors as regulating mitotic exit and late-born cell specification BS Clark, GL Stein-O’Brien, F Shiau, GH Cannon, E Davis-Marcisak, ... Neuron 102 (6), 1111-1126. e5, 2019 | 344 | 2019 |
| Residual function of cystic fibrosis mutants predicts response to small molecule CFTR modulators ST Han, A Rab, MJ Pellicore, EF Davis, AF McCague, TA Evans, AT Joynt, ... JCI insight 3 (14), 2018 | 96 | 2018 |
| Systematic computational identification of variants that activate exonic and intronic cryptic splice sites M Lee, P Roos, N Sharma, M Atalar, TA Evans, MJ Pellicore, E Davis, ... The American Journal of Human Genetics 100 (5), 751-765, 2017 | 83 | 2017 |
| Correlating cystic fibrosis transmembrane conductance regulator function with clinical features to inform precision treatment of cystic fibrosis AF McCague, KS Raraigh, MJ Pellicore, EF Davis-Marcisak, TA Evans, ... American journal of respiratory and critical care medicine 199 (9), 1116-1126, 2019 | 82 | 2019 |
| Functional assays are essential for interpretation of missense variants associated with variable expressivity KS Raraigh, ST Han, E Davis, TA Evans, MJ Pellicore, AF McCague, ... The American Journal of Human Genetics 102 (6), 1062-1077, 2018 | 80 | 2018 |
| Capitalizing on the heterogeneous effects of CFTR nonsense and frameshift variants to inform therapeutic strategy for cystic fibrosis N Sharma, TA Evans, MJ Pellicore, E Davis, MA Aksit, AF McCague, ... PLoS genetics 14 (11), e1007723, 2018 | 55 | 2018 |
| Integrated single-cell and bulk gene expression and ATAC-seq reveals heterogeneity and early changes in pathways associated with resistance to cetuximab in HNSCC-sensitive cell … LT Kagohara, F Zamuner, EF Davis-Marcisak, G Sharma, M Considine, ... BRITISH JOURNAL OF CANCER, 2020 | 49* | 2020 |
| Integrated single-cell and bulk gene expression and ATAC-seq reveals heterogeneity and early changes in pathways associated with resistance to cetuximab in HNSCC-sensitive cell … LT Kagohara, F Zamuner, EF Davis-Marcisak, G Sharma, M Considine, ... British Journal of Cancer, 1-13, 2020 | 44 | 2020 |
| Differential variation analysis enables detection of tumor heterogeneity using single-cell RNA-sequencing data EF Davis-Marcisak, TD Sherman, P Orugunta, GL Stein-O'Brien, ... Cancer research 79 (19), 5102-5112, 2019 | 32 | 2019 |
| Expression variation analysis for tumor heterogeneity in single-cell RNA-sequencing data EF Davis-Marcisak, P Orugunta, G Stein-O’Brien, SV Puram, ER Torres, ... BioRxiv, 479287, 2018 | 32* | 2018 |
| Evaluation of both exonic and intronic variants for effects on RNA splicing allows for accurate assessment of the effectiveness of precision therapies AT Joynt, TA Evans, MJ Pellicore, EF Davis-Marcisak, MA Aksit, ... PLoS genetics 16 (10), e1009100, 2020 | 30 | 2020 |
| Comprehensive analysis of retinal development at single cell resolution identifies NFI factors as essential for mitotic exit and specification of late-born cells BS Clark, GL Stein-O’Brien, F Shiau, GH Cannon, E Davis, T Sherman, ... bioRxiv, 378950, 2018 | 22 | 2018 |
| A sequence upstream of canonical PDZ-binding motif within CFTR COOH-terminus enhances NHERF1 interaction N Sharma, J LaRusch, PR Sosnay, LB Gottschalk, AP Lopez, MJ Pellicore, ... American Journal of Physiology-Lung Cellular and Molecular Physiology 311 (6 …, 2016 | 15 | 2016 |
| A novel mechanism of natural killer cell response to anti-CTLA-4 therapy identified by integrative analysis of mouse and human tumors EF Davis-Marcisak, AA Fitzgerald, MD Kessler, L Danilova, EM Jaffee, ... bioRxiv, 2020 | 6 | 2020 |
| Transfer learning identifies common cellular determinants of immune checkpoint inhibitor response between preclinical tumor models and patients EF Davis-Marcisak, AA Fitzgerald, N Zaidi, EM Jaffee, LM Weiner, ... Cancer Research 80 (16 Supplement), 3413-3413, 2020 | | 2020 |
| Single cell level treatment-specific characterization of HER2+ breast cancers treated with immune checkpoint inhibitors and entinostat DN Sidiropoulos, E Davis-Marcisak, C Rafie, LT Kagohara, G Sharma, ... Cancer Research 80 (16 Supplement), 1555-1555, 2020 | | 2020 |
| Characterization of the immune tumor microenvironment of HER2-positive breast cancer following treatment with entinostat and immune checkpoint inhibition. ET Roussos Torres, DN Sidiropoulos, E Davis-Marcisak, LT Kagohara, ... Journal of Clinical Oncology 38 (15_suppl), e15061-e15061, 2020 | | 2020 |
| Abstract P5-04-06: Reprogramming the suppressive tumor microenvironment of breast cancer ETR Torres, LT Kagohara, E Davis, C Rafie, B Christmas, Q Zhu, C Wang, ... Cancer Research 80 (4 Supplement), P5-04-06-P5-04-06, 2020 | | 2020 |
| Sequencing the tumor microenvironment and myeloid derived suppressor cells to understand response to immunotherapy in primary HER2 positive breast cancer ETR Torres, C Rafie, E Davis, LT Kagohara, EJ Fertig, EM Jaffee Cancer Research 79 (13 Supplement), 5027-5027, 2019 | | 2019 |
| THERATYPING OF CFTR SPLICING VARIANTS N Sharma, TA Evans, A Joynt, E Davis, M Pellicore, M Atalar, Z Lu, ... PEDIATRIC PULMONOLOGY 53, 204-204, 2018 | | 2018 |
